PMID: 9539572Apr 16, 1998Paper

Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL)

International Journal of Radiation Oncology, Biology, Physics
M BradaS Ashley

Abstract

To assess the efficacy and toxicity of combined modality therapy with short intensive primary chemotherapy in the treatment of primary CNS lymphoma (PCL). Prospective study of 31 nonimmunodeficient patients with PCL treated with initial chemotherapy (13 shortened MACOP-B; and 18 modified MACOP with high dose methotrexate) followed by radiotherapy (whole brain and a boost). Patients were aged 18-72 years (median 51 years). Eight patients had positive CSF cytology of which one had spinal meningeal disease; one patient had vitreous involvement. The overall complete response (CR) rate after chemotherapy and radiotherapy was 69% (95% Confidence Interval: 49-84%). At a median follow-up of 24 months (4 months to 10 years) median survival was 23 months and 5-year survival 34%. Age, sex, performance status, number of lesions, CSF cytology, and extent of surgery were not of prognostic significance for survival on univariate analysis. Eleven patients developed mucositis (Grade 3+) and 21 hematological toxicity (Grade 3+) with 22 septicemic episodes in 15 patients. Three patients developed dementia, one assumed to be treatment related, and two due to recurrent disease. The survival results of short intensive primary chemotherapy followed b...Continue Reading

References

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J OttB J Deehan
Nov 1, 1990·Neurology·W P Whitehouse, A C Young
May 1, 1985·Annals of Internal Medicine·P Klimo, J M Connors
Dec 1, 1988·Cancer·N L EbyP C Burger
Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·B P O'NeillR L Krigel
Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·M Brada
Jan 27, 1995·Transplantation·I Penn, G Porat
Jan 1, 1995·Journal of Neuro-oncology·K A Jellinger, W Paulus

❮ Previous
Next ❯

Citations

May 16, 2006·Journal of Neuro-oncology·Kristoph JahnkeUNKNOWN German Primary Central Nervous System Lymphoma Study Group
Oct 24, 2002·Current Treatment Options in Oncology·Scott R Plotkin, Tracy T Batchelor
Apr 9, 2002·Current Neurology and Neuroscience Reports·Leslie D McAllister
Apr 3, 2003·Current Treatment Options in Neurology·Denise M. Damek
Mar 29, 2002·Survey of Ophthalmology·Russell W ReadNarsing A Rao
May 31, 2001·International Journal of Radiation Oncology, Biology, Physics·E M BessellP Byrne
Apr 13, 2000·International Journal of Radiation Oncology, Biology, Physics·N HayabuchiY Onizuka
May 7, 1999·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·L LegrosJ L Lagrange
Feb 24, 2001·Journal of Pediatric Hematology/oncology·M E SilfenS E Oberfield
Dec 1, 2006·Neurosurgical Focus·Kristoph JahnkeEdward A Neuwelt
Mar 22, 2002·The Lancet Oncology·S R Plotkin, T T Batchelor
Feb 1, 2003·Lancet·Anthony BehinJean-Yves Delattre
Jul 2, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U Basso, A A Brandes
Dec 3, 1999·British Journal of Haematology·C R Pinkerton
Jul 21, 2014·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Byoung Hyuck KimDae Seog Heo
Oct 28, 2009·Clinical Lymphoma & Myeloma·Emanuela ChimientiUmberto Tirelli
Sep 22, 2009·Lancet·Andrés J M FerreriUNKNOWN International Extranodal Lymphoma Study Group (IELSG)
Jun 21, 2008·Revue neurologique·M Sierra Del RioK Hoang-Xuan
Jun 26, 2007·Critical Reviews in Oncology/hematology·Andrés J M Ferreri, Michele Reni
Jul 19, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·Y ShibamotoH Onishi
May 1, 2010·Expert Opinion on Pharmacotherapy·Matteo G CarrabbaAndrés J M Ferreri
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E M BessellFrancesc Graus
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tracy BatchelorRegina Priet
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrés J M FerreriTracy Batchelor
Feb 24, 2001·Hospital Medicine·S C Short, M Brada
Jun 1, 2006·Expert Review of Neurotherapeutics·Myke R GreenMarc Chamberlain
Oct 17, 2009·Expert Review of Neurotherapeutics·Kristoph Jahnke, Eckhard Thiel
May 13, 2009·The Oncologist·Monica Sierra del RioKhê Hoang-Xuan
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P O'BrienG Trotter

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.